Minimum 24 subjects aged 8-12 with a diagnosis of ADHD will be prescribed extended release guanfacine (Intuniv) to assess impact, if any, on working memory. Pre and post testing using a standardized battery of tests for effect on symptoms of ADHD and working memory will be administered and assessed.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
18
1-4 mg daily. Dose determined by response of ADHD symptoms to drug and by body mass limitations
3C Family Services
Cary, North Carolina, United States
Central Nervous System-Vital Signs (CNS-VS)
standardized computer administered battery
Time frame: 6-8 weeks on stable dose of study drug
Wide Range Assessment of Memory and Learning(WRAML)
psychologist administered battery assessing working memory
Time frame: 6-8 weeks on stable dose of study drug
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.